ACTION AGAINST AGE-RELATED MACULAR DEGENERATION
ACTION AGAINST AGE RELATED MACULAR DEGENERATION ('AAAMD') WILL FACILITATE FUND RAISING FOR BIOMEDICAL RESEARCH INTO THE TREATMENT OF AMD AND BE A DATA SOURCE OF RELATED INFORMATION. AAAMD IS AN EQUAL COLLABORATION BETWEEN BLIND VETERANS UK, FIGHT FOR SIGHT, MACULAR SOCIETY AND THE SCOTTISH WAR BLINDED. THE EXISTING CHARITABLE ACTIVITIES OF THE FOUNDERS WILL CONTINUE ALONGSIDE AAAMD.
Objects
FOR THE PUBLIC BENEFIT, THE ADVANCEMENT OF HEALTH BY RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF AGE-RELATED MACULAR DEGENERATION, INCLUDING BUT NOT LIMITED TO THE DEVELOPMENT OF RESEARCH INTO PRACTICAL APPLICATIONS FOR THE PREVENTION, TREATMENT AND CURE OF AGE-RELATED MACULAR DEGENERATION.
Financial health, per its FY2025 accounts
The accounts state that the charity generated unrestricted income of £121,763 against total group expenditure of £407,257, resulting in a net group deficit of £61,395. However, the trustees confirm the group has adequate resources to continue as a going concern, supported by cash reserves of £463,309 and a contingent loan facility. Free reserves of £283,249 are reported as being above the charity's stated policy target of six months of core cost expenditure.
What the accounts disclose
“Employee(s) received emoluments within the band £150,001 to £160,000” — page 25
“AAAMD’s reserve policy is set at six months of expected core cost expenditure.”
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Employees paid over £60,000: 2 (£60,001–£70,000: 1; £140,001–£150,000: 1)
- Trustee benefits, answered Yes to: any trustee benefit
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/03/2024
- Employees paid over £60,000: 1 (£140,001–£150,000: 1)
- Trustee benefits, answered Yes to: any trustee benefit
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/03/2023
- Employees paid over £60,000: 1 (£140,001–£150,000: 1)
- Trustee benefits, answered Yes to: any trustee benefit
- Has a trading subsidiary
Corporate structure
- Trading subsidiary: FORESIGHT RESEARCH LIMITED Companies House 12048839 · Financial health read from its filings
- Trading subsidiary: FORESIGHT RESEARCH SCOTLAND LIMITED Companies House SC633501
- Issued share capital consists of 100 Ordinary Shares of £1 each, held by the parent charity.
- Profit before tax: £-208k
- The company has received £500,000 as a Programme Related Investment (loan) from several charities, which is unsecured, has no fixed repayment schedule, and is only repayable if certain turnover or profitability levels are achieved.
Trustees
- Mark O'Donnellchair
- Adrian Bell
- CATHERINE MARY YELF
- Craig Douglas Spalding
- Dr Antonius Rijnders
- Edward James Holloway
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £122k | £407k |
| 31/03/2024 | £291k | £443k |
| 31/03/2023 | £354k | £356k |
| 31/03/2022 | £350k | £306k |
| 31/03/2021 | £211k | £313k |
Common questions
Is ACTION AGAINST AGE-RELATED MACULAR DEGENERATION financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated unrestricted income of £121,763 against total group expenditure of £407,257, resulting in a net group deficit of £61,395. However, the trustees confirm the group has adequate resources to continue as a going concern, supported by cash reserves of £463,309 and a contingent loan facility. Free reserves of £283,249 are reported as being above the charity's stated policy target of six months of core cost expenditure. Its FY2025 accounts were audited by Wenn Townsend.
What does the highest-paid employee of ACTION AGAINST AGE-RELATED MACULAR DEGENERATION earn?
Per its FY2025 accounts, the highest-paid employee was in the £150,001 - £160,000 band.
Who funds ACTION AGAINST AGE-RELATED MACULAR DEGENERATION?
Funders whose own accounts filings name ACTION AGAINST AGE-RELATED MACULAR DEGENERATION as a grant recipient include SCHRODER CHARITY TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| SCHRODER CHARITY TRUST | FY2024 | £5k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE LANCASHIRE FOUNDATION | 1 | £6k |
| SIR SAMUEL SCOTT OF YEWS TRUST | 1 | £5k |
Charities like this
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ACTION AGAINST AGE-RELATED MACULAR DEGENERATION | £122k | £150,001 - £160,000 | — | above | — | no doubt |
| AMR Action UK | £369k | — | 0 | unclear | — | no doubt |
| THE AMR NARRATIVE | £36k | — | 0 | unclear | — | no doubt |
| MEMORY ACTION GROUP | £75k | — | — | above | — | no doubt |
| LAM ACTION | £158k | — | 0 | above | — | no doubt |